Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

NCT07460752 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Locally Advanced Hormone Receptor-Positive Breast Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Goserelin Acetate
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic